Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-377P is a pseudogene of U6 small nuclear RNA, located on human chromosome 3[2][4]. Unlike the functional U6 snRNA, which plays a central role in spliceosome-mediated pre-mRNA splicing[5], RNU6-377P does not encode a functional RNA or protein. Pseudogenes like RNU6-377P are non-coding genomic sequences that originate from duplication events of functional genes and are typically transcriptionally inactive or quickly degraded; they lack the promoter elements, regulatory regions, or structural characteristics necessary for stable expression and cellular function[1][4]. The U6 small nuclear RNA itself (not the pseudogene) is integral to mRNA splicing but this specific pseudogene does not perform any known biological or pathological role. There is no evidence of transcriptional activity, disease association, or utility as a drug target for RNU6-377P[1][4]. If you seek information on drug targets, disease involvement, or molecular biology, reference should be made to "U6 small nuclear RNA" rather than its pseudogene derivatives, such as RNU6-377P[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 377, pseudogene (RNU6-377P).